Shanghai Haohai Biological Technology Co., Ltd.

SHSC:6826 Stock Report

Market Cap: HK$15.0b

Shanghai Haohai Biological Technology Balance Sheet Health

Financial Health criteria checks 5/6

Shanghai Haohai Biological Technology has a total shareholder equity of CN¥6.0B and total debt of CN¥423.7M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are CN¥7.2B and CN¥1.2B respectively. Shanghai Haohai Biological Technology's EBIT is CN¥404.8M making its interest coverage ratio -6.4. It has cash and short-term investments of CN¥2.7B.

Key information

7.0%

Debt to equity ratio

CN¥423.70m

Debt

Interest coverage ratio-6.4x
CashCN¥2.69b
EquityCN¥6.03b
Total liabilitiesCN¥1.21b
Total assetsCN¥7.25b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 6826's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥861.5M).

Long Term Liabilities: 6826's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥350.6M).


Debt to Equity History and Analysis

Debt Level: 6826 has more cash than its total debt.

Reducing Debt: 6826's debt to equity ratio has increased from 0.7% to 7% over the past 5 years.

Debt Coverage: 6826's debt is well covered by operating cash flow (159%).

Interest Coverage: 6826 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies